Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Alan Thompson
Institute of Neurology
Department of Brain Repair and Rehabilitation
Queen Square
  • Garfield Weston Professor of Clinical Neurology & Neurorehabilitation
  • Faculty of Brain Sciences
  • School of Life & Medical Sciences

Alan Thompson is Dean of the UCL Faculty of Brain Sciences, and Programme Director for Neurological Disorders, UCL Partners Academic Health Science Centre.  He is an NIHR Senior Investigator, honorary consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, a Guarantor of Brain, and Editor-in-Chief of Multiple Sclerosis Journal.  Alan Thompson  has an H-index of 86 (Research ID C-2654-2008), and is ranked 22nd in the Essential Science Indicators section for Neuroscience and Behavior.  He received his undergraduate degrees in 1979 and MD in 1985 from Trinity College Dublin, was elected FRCP in 1994, FRCPI in 1995, FAAN in 2009, and received an honorary doctorate from Hasselt University, Belgium, in 2008.  He was awarded the 'Pioneer of the Nation' award at Buckingham Palace in 2003.  His MD on immunological and biochemical markers of disease activity in multiple sclerosis (MS) demonstrated for the first time active demyelination shown by the detection of breakdown products of myelin basic protein in the CSF in the absence of clinical symptoms.  His post-doctorate research has been at the UCL Institute of Neurology and the National Hospital, Queen Square, where he carried out the first serial MRI studies of the natural history of individual disease groups in MS, demonstrating the value of MRI in monitoring the disease process, and developed protocols used internationally for the use of MRI in assessing the effectiveness of new treatments. He has developed MR techniques which improve pathological specificity, and developed techniques for measuring spinal cord atrophy and cerebral atrophy (indicating axonal loss).  He has identified the unique characteristics of the primary progressive MS group, and is a member of a group of international experts who defined diagnostic criteria for MS in 2001, 2005 and 2010.   In 1998 Alan Thompson was appointed to the first chair of Clinical Neurology and Neurorehabilitation in the UK, and in 2007 established and led the Department of Brain Repair and Rehabilitation at the UCL Institute of Neurology.  He is chair of MSIF's International Medical and Scientific Board, Chair of the Steering Committee for the International Progressive MS Collaborative, a member of the National MS Society (USA)'s Research Programs Advisory Committee, and a Guarantor of Brain. 

Research Summary

Heads group using magnetic resonance imaging (MRI) to evaluate the underlying pathology of multiple sclerosis (MS), measure brain atrophy, and establish reliable markers for disease progression and extent of disability.  Methods are being developed to measure grey matter atrophy and abnormalities accurately, which, when incorporated into clinical trials as an outcome measure, will allow effective treatments to be identified, and show the likely relationship between grey matter atrophy and physical disability and cognitive impairment.

With Dr Olga Ciccarelli studies mechanisms of damage in acute lesions affecting the motor tracts and, in particular, the effect they have on the axons that traverse them.  New research hopes to establish the role of mitochondrial dysfunction in MS and whether the reversibility of mitochondrial dysfunction causes clinical improvement in MS patients.    With Dr Ahmed Toosy studies structural/functional recovery mechanisms following optic neuritis to develop new strategies to enhance recovery and identify effective treatments.  Collaborates with Dr Patrick Freund and team using imaging to identify morphometric changes which may predict clinical recovery after spinal cord injury.  Supports Bernadette Porter, MS Nurse Consultant, in developing NeuroResponse, providing high quality telecare to patients with MS.

Member of international group of experts who have published criteria for the diagnosis of MS.  Leads research to define the imaging characteristics, diagnostic criteria, and underlying disease progression for primary progressive multiple sclerosis, using a unique cohort of patients.

As Programme Director for the Neurological Disorders theme for UCL Partners oversees development of the stroke service, applying a quality metric across the entire pathway with Dr Charlie Davie.  A combined research and clinical strategy for brain cancer has culminated in a unified, single-site neurosurgical service and a dedicated Brain Tumour Centre for North Central London, and a collaborative research programme with the Cancer Institute.  Work continues to commission the entire pathway and to identify quality metrics.  Research into neurodegenerative disease is developing to enhance understanding, diagnosis, and treatment, and to create a dedicated national resource for testing novel therapies.  Using a combination of novel biomarkers, at-risk cohorts, and sensitive and precise measures of progression, early proof of concept studies are planned which will involve an interdisciplinary, cross-disease approach to identify potential disease-modifying therapies.

Work on Neurological Outcome Measures focuses on the development, evaluation, and application of rating scales to measure health outcomes, predominantly from the patients' perspective.  Amongst the achievements are the MS Walking Scale, which contributed to the recent approval of a symptomatic treatment for MS (Fampridine), validation of a generic walking scale, and the MS Impact Scale (MSIS-29 with Professor Jeremy Hobart), The MS Impact Scale and the MS Walking Scale are used in clinical trials and epidemiological studies world-wide.

In neurological disability management, Alan Thompson has worked on Quality Standards (2005); the MS World Atlas (with WHO/MSIF, 2008), and the Global Economic Study (with MSIF, 2010).  He is currently part of the WHO Advisory Group revising the ICD-10 for Neurological Disorders.  The Neurological Rehabilitation Unit studies goal-setting and vocational rehabilitation (Dr Diane Playford), treatment of MS relapses (Dr Jeremy Chataway, Bernie Porter), and spasticity (Dr Val Stevenson).    


Teaching Summary

Involved in multidisciplinary teaching to medical students, post-graduate students, nurses and therapists, focusing on MRI, neurorehabilitation, and the management of disability; special focus on multiple sclerosis.
Participates in short courses run by Institute of Neurology.
As Director of Institute of Neurology fostered growth of the Education Unit to establish a four-year PhD programme in Clinical Neuroscience, a new MSc course in Advanced Neuroimaging, an online MSc for neurology trainees, and developing a distance learning postgraduate diploma in neuroscience (e-Brain) with the Joint Neurosciences Council and the EFNS.  Within the CBRC launched an MSc in Translational Medicine. 
Established National Treasure post in neurorehabilitation and curriculum for neurology SpRs in last year of training.
As Medical Advisor to the MS Society and now the MSIF, involved in production of educational materials for patients relating to diagnosis, treatment and management of MS.
International teaching role:  Teaches regularly in courses and workshops on neurorehabilitation, outcome measurement, MRI, and diagnosis and management of multiple sclerosis aimed at researchers, physicians, specialist nurses, therapists, and patient groups.  Named lectures include the Gowers Memorial Lecture Queen Square, May 2009, and the BS Singhal Oration at the ABN/Indian Neurological Association meeting, Mumbai, 2007.
Has edited textbooks on multiple sclerosis and is editor-in-chief of Multiple Sclerosis Journal.

01-AUG-2011 Dean Faculty of Brain Sciences, SLMS University College London, United Kingdom
01-MAR-2011 – 01-AUG-2011 Transitional Dean Faculty of Biomedical Sciences University College London, United Kingdom
01-NOV-2010 Interim Chair Neuroscience Domain, SLMS University College London, United Kingdom
2009 – 2012 Programme Director Neurological Disorders Theme UCL Partners Academic Health Science Centre, United Kingdom
01-APR-2008 – 03-JAN-2012 Director Institute of Neurology University College London, United Kingdom
2008 – 2013 Senior Investigator National Institute for Health Research DOH, United Kingdom
2006 – 2010 Deputy Director Comprehensive Biomedical Research Centre NIHR, United Kingdom
2006 – 2008 Deputy Director Joint UCLH/UCL R&D Unit  , United Kingdom
2003 – 2007 Divisional Clinical Director Neurosciences National Hospital for Neurology and Neurosurgery, United Kingdom
1998 Garfield Weston Professor of Clin Neurol/Neurorehabilitation Institute of Neurology University College London, United Kingdom
1990 Honorary Consultant Neurologist Neurology National Hospital for Neurology and Neurosurgery, United Kingdom
Academic Background
1995 FRCP Fellow of the Royal College of Physicians – Medicine Royal College of Physicians of Ireland
1994 FRCP Fellow of the Royal College of Physicians – Medicine Royal College of Physicians
1985 MD Doctor of Medicine – Medicine Trinity College Dublin
1979 BA Bachelor of Arts – Medicine/Surgery Trinity College Dublin
1979 BAO Bachelor of the Arts of Obstetrics – Obstetrics and Gynaecology Trinity College Dublin
Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by